TASIGNA
NILOTINIB
Active substance
NILOTINIB
Laboratory
NOVARTIS PHARMA
What is this medicine?
Nilotinib is a kinase inhibitor used for the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML).
Verified summary
NILOTINIB, GELULE, 400 MG, BOITE DE 28
Common uses
Treatment of newly diagnosed Ph+ CML in chronic phase for adult and pediatric patients (1 year and older), as well as adult and pediatric patients with Ph+ CML who are resistant or intolerant to prior therapies such as imatinib or other tyrosine-kinase inhibitors.
Class
Kinase inhibitor
Laboratory
NOVARTIS PHARMA
Strength
400 MG
Form
GELULE
Presentation
BOITE DE 28
Commercial status
Non commercialisé / Sans Prix
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: Not available in the verified source